ARGE Bachleitner/ Friedl/Stift: Publications
Laborbezogene Publikationen aus 2011
- Antitumor activity of SNX-2112, a synthetic heat shock protein-90 inhibitor, in MET-amplified tumor cells with or without resistance to selective MET Inhibition.
Bachleitner-Hofmann T, Sun MY, Chen CT, Liska D, Zeng Z, Viale A, Olshen AB, Mittlboeck M, Christensen JG, Rosen N, Solit DB, Weiser MR.
Clin Cancer Res. 2011 Jan 1;17(1):122-33.
- HGF rescues colorectal cancer cells from EGFR inhibition via MET activation.
Liska D, Chen CT, Bachleitner-Hofmann T, Christensen JG, Weiser MR.
Clin Cancer Res. 2011 Feb 1;17(3):472-82. Epub 2010 Nov 22.